607 F.Supp.2d 614 (D.Del. 2009), C. A. 05-642, Alza Corp. v. Andrx Pharmaceuticals, LLC

Citation: 607 F.Supp.2d 614

Opinion Judge: FARNAN, District Judge.

Party Name: ALZA CORPORATION and McNeil-PPC, Inc., Plaintiffs, v. ANDRX PHARMACEUTICALS, LLC, and Andrx Corporation, Defendants.

Attorney: David T. Pritikin, Esquire and Thomas D. Rein, Esquire of Sidley Austin LLP, New York, NY, Jeffery P. Kushan, Esquire and Todd A. Wagner, Esquire of Sidley Austin LLP, Washington, D.C., Michael D. Hatcher, Esquire of Sidley Austin LLP, Dallas, TX, Steven J. Balick, Esquire and John G. Day, Esquir...

Case Date: March 30, 2009

Court: U.S. District Court — District of Delaware

Linked as:

Document options

Printable page
Email this

Extract

607 F.Supp.2d 614 (D.Del. 2009), C. A. 05-642, Alza Corp. v. Andrx Pharmaceuticals, LLC

No longer available (Autolink)

See the full content of this document

This document cites

US Code - 35 U.S.C. § 103 Conditions For Patentability; Non-Obvious Subject Matter
US Code - 35 U.S.C. § 112 Specification
US Code - 35 U.S.C. § 271 Infringement of Patent
US Code - 21 U.S.C. § 321 Definitions; Generally
Federal Cases - Bell Communications Research, Inc. v. Vitalink Communications Corp.

See all quotations